Another sort of test is possible. By looking at who’s already had COVID-19, rather than who has it now, we could help healthcare workers stay on the job.
A doctor and researcher explains some of the reasons the U.S. has lagged in developing a COVID-19 test.
Global supply chains may radically realign following this painfully destabilizing episode. Companies are already moving production out of China, and next they may move away from those pesky, disease-prone people.
Given the costs of epidemics, stable, strategic investments in organizations and activities dedicated to outbreak preparedness, prevention, mitigation and response are critical.